Intercept reduces debt with repurchases of $327.9M convertible notes

Aug. 19, 2022 7:51 AM ETIntercept Pharmaceuticals, Inc. (ICPT)By: Preeti Singh, SA News Editor
  • Intercept Pharmaceuticals (NASDAQ:ICPT) has entered into privately negotiated agreements to repurchase $327.9M of its secured convertible debt using a combination of cash and equity, the biopharmaceutical company announced on Friday.
  • The repurchase is among a series of strategic financial moves

Recommended For You

Comments

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.